L N Antipova

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

Plain English
This study looked at how primary progressive multiple sclerosis (PPMS) is diagnosed in different areas of Russia. It highlighted that identifying patients with PPMS quickly is important, as delays can affect treatment and care. For example, the research showed that timely diagnosis can significantly improve patients' quality of life. Who this helps: This benefits patients with primary progressive multiple sclerosis and their doctors.

Plain English
This study looked at how effective Botulinum toxin type A (BoNT-A) injections are for helping people with muscle stiffness in their arms after a stroke. Out of 41 patients in Russia, nearly 88% achieved improvement in their treatment goals, with complete success in improving passive function and 95% achieving better movement range. This is important because it shows that BoNT-A can significantly enhance the daily lives of stroke survivors by reducing muscle stiffness and improving movement. Who this helps: This benefits stroke patients dealing with upper-limb spasticity.